## SECTION IV - CREDIBILITY ASSESSMENT (ISPOR-AMCP-NPC)

### 34. Evidence Base Credibility

| Item | Assessment Criterion                                                                                    | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 34.1 | **Search Comprehensiveness**: Was the literature search comprehensive and unbiased?                     | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 34.2 | **Study Selection Transparency**: Were study selection criteria applied consistently and transparently? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 34.3 | **Data Extraction Quality**: Was data extraction systematic, with quality control procedures?           | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 34.4 | **Individual Study Quality**: Are individual studies of sufficient quality for inclusion?               | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 34.5 | **Quality Impact**: Has the impact of study quality on NMA results been evaluated?                      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 35. Analysis Methods Credibility

| Item | Assessment Criterion                                                                                          | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 35.1 | **Pairwise Comparison**: Were direct pairwise meta-analyses conducted and compared with NMA results?          | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 35.2 | **Statistical Validity**: Was the statistical model appropriate for the data structure and research question? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 35.3 | **Assumption Testing**: Were key assumptions (transitivity, consistency, homogeneity) adequately tested?      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 35.4 | **Sensitivity Robustness**: Did sensitivity analyses demonstrate robustness of results?                       | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 35.5 | **Model Convergence**: For Bayesian analyses, was adequate convergence achieved?                              | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 36. Reporting Quality & Transparency

| Item | Assessment Criterion                                                                                                             | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | -------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 36.1 | **Methodological Detail**: Is sufficient methodological detail provided to replicate the analysis?                               | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 36.2 | **Result Completeness**: Are all relevant results reported (including non-significant findings)?                                 | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 36.3 | **Uncertainty Communication**: Is uncertainty appropriately characterized and communicated (CI, PrI, probability distributions)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 36.4 | **Visual Presentation**: Are results presented clearly with appropriate figures (network diagrams, forest plots, league tables)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 37. Interpretation of Findings

| Item | Assessment Criterion                                                                                             | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 37.1 | **Balanced Interpretation**: Are conclusions balanced and justified by the evidence?                             | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 37.2 | **Limitation Acknowledgment**: Are important limitations acknowledged and their impact on conclusions discussed? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 37.3 | **Clinical Context**: Are findings interpreted in appropriate clinical and healthcare context?                   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 37.4 | **Overstated Claims**: Are authors avoiding overstatement of findings or causal claims?                          | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 38. Conflicts of Interest

| Item | Assessment Criterion                                                                                   | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 38.1 | **Author COI**: Are author conflicts of interest transparently declared?                               | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 38.2 | **Funding Influence**: Could funding sources have influenced study design, conduct, or interpretation? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 38.3 | **Industry Involvement**: If industry-funded, are appropriate safeguards against bias evident?         | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

---
